3-[1-(ethylamino)cyclohexyl]phenol
3-HO-PCE is a dissociative arylcyclohexylamine that primarily acts as an NMDA receptor antagonist. It produces dissociative effects similar to other substances in this class, with effects depending on dosage and individual factors. The substance is used in research and recreational contexts, with potential risks including neurotoxic effects and psychological distress.
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Designations
IUPAC: 3-[1-(ethylamino)cyclohexyl]phenol
Synapedia Evidence
Effects & Pharmacology is partially translated. Some details are still being expanded.
3-HO-PCE functions mainly as an NMDA receptor antagonist, contributing to its dissociative properties.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Risks & Harm Reduction translation in progress
English prose is being expanded. Safety-critical structured data may still be shown when available.
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.